Bevacizumab Biosimilars Global Market Report 2023 – Market Dimension, Developments, And Global Forecast 2023-2032 The Enterprise Analysis Firm’s Bevacizumab Biosimilars Gl… Read More

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More

The words biology and pharmaceuticals are combined to define “biopharmaceuticals.” Biopharmaceuticals are medicines created utilizing living cells or organisms, as their name sug… Read More

Roots Analysis Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings. Owing to the numerous bene… Read More

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2022 The Business Research Company’s Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market R… Read More

Recent support of FDA on avastin biosimilar opens up hope for the cancer patients. Biosimilars are large, structurally complex molecules that are intended to be highly similar to, and treat… Read More

Transparency Market Research (TMR) has published a new report titled, ‘High Potency Active Pharmaceutical Ingredients (HPAPI) Market - Global Industry Analysis, Size, Share, Gro… Read More

The biosimilars market is predicted to reach $26.7 billion by 2024, progressing at a CAGR of 29.6% during the forecast period (2019–2024), according to P&S Intelligence. The market… Read More

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and are suita… Read More

frolicsomepl / Pixabay The News: Amgen Inc. (Thousand Oaks CA) and Allergan PLC (Dublin IRL) said Thursday (September 14, 2017) that the Food and Drug Administration has approved their biosi… Read More

Oncology was one of the largest and fastest growing segments of the Global Biosimilars Market in 2013. But the market is expected to more than triple in size by 2018, surpassing the billion… Read More

Evaluate Pharma, a well-known market research organization in the field of medicine, recently released the report “EP Vantage 2018 Preview”, in which it reviewed the new drug ap… Read More

kalhh / Pixabay The News: Amgen Inc. (Thousand Oaks CA) has agreed to delay the US launch of its FDA-approved biosimilar version of AbbVie Inc.’s (North Chicago) Humira (adalimumab) un… Read More